Tk(+/-) mouse model for detecting in vivo mutation in an endogenous, autosomal gene

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 423, Issue 1-2, 1999, Pages 125-136

  Dobrovolsky, Vasily N ^a   Casciano, Daniel A ^a   Heflich, Robert H ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

5 bromo 2' deoxyuridine; Knockout; Mutation; N ethyl N nitrosourea; Thymidine kinase

Indexed keywords

BROXURIDINE; ETHYLNITROSOUREA; THYMIDINE KINASE; TIOGUANINE; TRIFLURIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOSOME; CONTROLLED STUDY; FEMALE; GENE INACTIVATION; GENE MUTATION; GENETIC RECOMBINATION; LYMPHOCYTE CLONE; MALE; MOUSE; MUTATION RATE; NEWBORN; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; SPLEEN LYMPHOCYTE; TRANSGENE;

ANIMALS; CROSSES, GENETIC; ETHYLNITROSOUREA; FEMALE; GENES; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, GENETIC; MUTAGENESIS; THYMIDINE KINASE;

ANIMALIA; MUS MUSCULUS;

EID: 0033601826     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00234-6     Document Type: Article

References (54)

1. Tennant R.W., Margolin B.H., Shelby M.D., Zeiger E., Haseman J.K., Spalding J., Caspary W., Resnick M., Stasiewicz S., Anderson B. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science. 236:1987;933-941.
2. Aidoo A., Lyn-Cook L.E., Mittelstaedt R.A., Heflich R.H., Casciano D.A. Induction of 6-thioguanine-resistant lymphocytes in Fischer 344 rats following in vivo exposure to N-ethyl-N-nitrosourea and cyclophosphamide. Environ. Mol. Mutagen. 17:1991;141-151.
3. Jones I.M., Burkhart-Schultz K., Carrano A.V. A method to quantify spontaneous and in vivo induced thioguanine-resistant mouse lymphocytes. Mutat. Res. 147:1985;97-105.
4. Zimmer D.M., Aaron C.S., O'Neill J.P., Albertini R.J. Enumeration of 6-thioguanine-resistant T-lymphocytes in the peripheral blood of nonhuman primates (cynomolgus monkeys). Environ. Mol. Mutagen. 18:1991;161-167.
5. Stout J.T., Caskey C.T. HPRT: gene structure, expression, and mutation. Annu. Rev. Genet. 19:1985;127-148.
6. DeMarini D.M., Brockman H.E., de Serres F.J., Evans H.H., Stankowski L.F.J., Hsie A.W. Specific-locus mutations induced in eukaryotes (especially mammalian cells) by radiation and chemicals: a perspective. Mutat. Res. 220:1989;11-29.
7. Evans H.H., Mencl J., Horng M.F., Ricanati M., Sanchez C., Hozier J. Locus specificity in the mutability of L5178Y mouse lymphoma cells: the role of multilocus lesions. Proc. Natl. Acad. Sci. U.S.A. 83:1986;4379-4383.
8. Hozier J., Applegate M., Moore M.M. In vitro mammalian mutagenesis as a model for genetic lesions in human cancer. Mutat. Res. 270:1992;201-209.
9. Moore M.M., Amtower A., Strauss G.H.S., Doerr C. Genotoxicity of γ-irradiation in L5178Y mouse lymphoma cells. Mutat. Res. 174:1986;149-154.
10. - mutants. Mutat. Res. 377:1997;27-36.
11. Burkhart J.G., Burkhart B.A., Sampson K.S., Malling H.V. ENU-induced mutagenesis at a single A:T base pair in transgenic mice containing ΦX174. Mutat. Res. 292:1993;69-81.
12. Dycaico M.J., Provost G.S., Kretz P.L., Ransom S.L., Moores J.C., Short J.M. The use of shuttle vectors for mutation analysis in transgenic mice and rats. Mutat. Res. 307:1994;461-478.
13. Gossen J.A., de Leeuw W.J., Tan C.H., Zwarthoff E.C., Berends F., Lohman P.H., Knook D.L., Vijg J. Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc. Natl. Acad. Sci. U.S.A. 86:1989;7971-7975.
14. Kohler S.W., Provost G.S., Fieck A., Kretz P.L., Bullock W.O., Sorge J.A., Putman D.L., Short J.M. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 88:1991;7958-7962.
15. Manjanatha M.G., Shelton S.D., Aidoo A., Lyn-Cook L.E., Casciano D.A. Comparison of in vivo mutagenesis in the endogenous hprt gene and the lacI transgene of Big Blue® rats treated with 7,12-dimethylbenz[a]anthracene. Mutat. Res. 401:1998;165-178.
16. Skopek T.R., Kort K.L., Marino D.R. Relative sensitivity of the endogenous Hprt gene and lacI transgene in ENU-treated Big Blue™ B6C3F1 mice. Environ. Mol. Mutagen. 26:1995;9-15.
17. Gorelick N.J. Overview of mutation assays in transgenic mice for routine testing. Environ. Mol. Mutagen. 25:1995;218-230.
18. Tao K.S., Urlando C., Heddle J.A. Comparison of somatic mutation in a transgenic versus host locus. Proc. Natl. Acad. Sci. U.S.A. 90:1993;10681-10685.
19. Winegar R.A., Lutze L.H., Hamer J.D., O'Loughlin K.G., Mirsalis J.C. Radiation-induced point mutations, deletions and micronuclei in lacI transgenic mice. Mutat. Res. 307:1994;479-487.
20. Dass S.B., Heflich R.H., Casciano D.A. The mutagenic response at the ouabain resistance locus in T cells of mice exposed to N-ethyl-N-nitrosourea parallels the response at the Hprt locus and correlates with mutation target size. Carcinogenesis. 18:1997;2233-2237.
21. Winton D.J., Blount M.A., Ponder B.A. A clonal marker induced by mutation in mouse intestinal epithelium. Nature. 333:1988;463-466.
22. Adair G.M., Carver J.H., Wandres D.L. Mutagenicity testing in mammalian cells. I. Derivation of a Chinese hamster ovary cell line heterozygous for the adenine phosphoribosyltransferase and thymidine kinase loci. Mutat. Res. 72:1980;187-205.
23. Bradley W.E., Letovanec D. High-frequency nonrandom mutational event at the adenine phosphoribosyltransferase (aprt) locus of sib-selected CHO variants heterozygous for aprt. Somatic Cell Genet. 8:1982;51-66.
24. Clive D., Flamm W.G., Machesko M.R., Bernheim N.J. A mutational assay system using the thymidine kinase locus in mouse lymphoma cells. Mutat. Res. 16:1972;77-87.
25. Skopek T.R., Liber H.L., Penman B.W., Thilly W.G. Isolation of a human lymphoblastoid line heterozygous at the thymidine kinase locus: possibility for a rapid human cell mutation assay. Biochem. Biophys. Res. Commun. 84:1978;411-416.
26. +/- embryonic stem cell line for use in mutagenicity studies. Environ. Mol. Mutagen. 28:1996;483-489.
27. Engle S.J., Stockelman M.G., Chen J., Boivin G., Yum M.N., Davies P.M., Ying M.Y., Sahota A., Simmonds H.A., Stambrook P.J., Tischfield J.A. Adenine phosphoribosyltransferase-deficient mice develop 2,8-dihydroxyadenine nephrolithiasis. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5307-5312.
28. Stambrook P.J., Shao C., Stockelman M., Boivin G., Engle S.J., Tischfield J.A. APRT: a versatile in vivo resident reporter of local mutation and loss of heterozygosity. Environ. Mol. Mutagen. 28:1996;471-482.
29. B. Hogan, R. Beddington, F. Costantini, E. Lacy, Manipulating the Mouse Embryo, A Laboratory Manual, 2nd edn., Cold Spring Harbor Laboratory Press, Plainview, NY (1994).
30. Liechty M.C., Crosby H.J., Murthy A., Davis L.M., Caspary W.J., Hozier J.C. Identification of a heteromorphic microsatellite within the thymidine kinase gene in L5178Y mouse lymphoma cells. Mutat. Res. 371:1996;265-271.
31. Lin P.F., Lieberman H.B., Yeh D.B., Xu T., Zhao S.Y., Ruddle F.H. Molecular cloning and structural analysis of murine thymidine kinase genomic and cDNA sequences. Mol. Cell Biol. 5:1985;3149-3156.
32. Meng Q., Skopek T., Walker D.M., Hurley-Leslie S., Chen T., Zimmer D.M., Walker V.E. Culture and propagation of hprt mutant T-lymphocytes isolated from mouse spleen. Environ. Mol. Mutagen. 32:1998;236-243.
33. -/- mutants. Mutat. Res. 286:1993;299-307.
34. Wintersberger E. Regulation and biological function of thymidine kinase. Biochem. Soc. Trans. 25:1997;303-308.
35. Fye K.H., Sahota A., Hancock D.C., Gelb A.B., Chen J., Sparks J.W., Sibley R.K., Tischfield J.A. Adenine phosphoribosyltransferase deficiency with renal deposition of 2,8-dihydroxyadenine leading to nephrolithiasis and chronic renal failure. Arch. Intern. Med. 153:1993;767-770.
36. Sculley D.G., Dawson P.A., Emmerson B.T., Gordon R.B. A review of the molecular basis of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. Hum. Genet. 90:1992;195-207.
37. Hooper M., Hardy K., Handyside A., Hunter S., Monk M. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature. 326:1987;292-295.
38. Kuehn M.R., Bradley A., Robertson E.J., Evans M.J. A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature. 326:1987;295-298.
39. +/- mouse lymphoma cells. Mutat. Res. 85:1981;363-378.
40. Yandell D.W., Dryja T.P., Little J.B. Somatic mutations at a heterozygous autosomal locus in human cells occur more frequently by allele loss than by intragenic structural alterations. Somatic Cell Mol. Genet. 12:1986;255-263.
41. Morris S.M. The genetic toxicology of 5-bromodeoxyuridine in mammalian cells. Mutat. Res. 258:1991;161-188.
42. +/- mouse lymphoma cells at varying times post-treatment. Environ. Mutagen. 4:1982;499-519.
43. 6-alkylguanine-DNA alkyltransferase. Proc. Natl. Acad. Sci. U.S.A. 86:1989;8620-8624.
44. 4-ethylthymine adducts in HeLa cells. Nucleic Acids Res. 18:1990;4131-4137.
45. Preston B.D., Singer B., Loeb L.A. Comparison of the relative mutagenicities of O-alkylthymines site-specifically incorporated into ΦX174 DNA. J. Biol. Chem. 262:1987;13821-13827.
46. 4-Methyl, -ethyl, or -isopropyl substituents on thymidine in poly(dA-dT) all lead to transitions upon replication. Proc. Natl. Acad. Sci. U.S.A. 83:1986;28-32.
47. 1 mice exposed to N-ethyl-N-nitrosourea. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7866-7870.
48. Walker V.E., Gorelick N.J., Andrews J.L., Craft T.R., deBoer J.G., Glickman B.W., Skopek T.R. Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice. Cancer Res. 56:1996;4654-4661.
49. Burns P.A., Gordon A.J., Kunsmann K., Glickman B.W. Influence of neighboring base sequence on the distribution and repair of N-ethyl-N-nitrosourea-induced lesions in Escherichia coli. Cancer Res. 48:1988;4455-4458.
50. Richardson K.K., Richardson F.C., Crosby R.M., Swenberg J.A., Skopek T.R. DNA base changes and alkylation following in vivo exposure of Escherichia coli to N-methyl-N-nitrosourea or N-ethyl-N-nitrosourea. Proc. Natl. Acad. Sci. U.S.A. 84:1987;344-348.
51. +/- mouse lymphoma cells. Mutagenesis. 5:1990;191-197.
52. Cole J., Skopek T.R. International Commission for Protection Against Environmental Mutagens and Carcinogens. Working paper no. 3. Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo. Mutat. Res. 304:1994;33-105.
53. Chen T., Aidoo A., Manjanatha M.G., Mittelstaedt R.A., Shelton S.D., Lyn-Cook L.E., Casciano D.A., Heflich R.H. Comparison of mutant frequencies and types of mutations induced by thiotepa in the endogenous Hprt gene and transgenic lacI gene of Big Blue® rats. Mutat. Res. 403:1998;199-214.
54. Combes R.D., Stopper H., Caspary W.J. The use of L5178Y mouse lymphoma cells to assess the mutagenic, clastogenic and aneugenic properties of chemicals. Mutagenesis. 10:1995;403-408.